Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Conditions:   Breast Cancer;   HER2-positive Breast Cancer;   HER-2 Gene Amplification;   HER2 Positive Breast Carcinoma;   HER-2 Protein Overexpression;   Breast Cancer, Male;   Breast Cancer Female Intervention:   Biological: HER2 DC1 Vaccine Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Pennies in Action Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials